Ayser Al-Husseini 1, Donatas Kraskauskas 1, Eleanora Mezzaroma 2, Andrea Nordio 2, Daniela Farkas 1, Jennifer I. Drake 1, Antonio Abbate 2, Quentin Felty 3, Norbert F. Voelkel 1, Vascular endothelial ...

Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells. Experimental Biology and Medicine , 2015; 240 (12): 1580 DOI: 10.1177 ...

Endothelial dysfunction markers were linked to future disease activity and complications in lcSSc.

Mark R. Nicolls 1, Shiro Mizuno 2, Laima Taraseviciene-Stewart 3, Laszlo Farkas 4, Jennifer I. Drake 4, Aysar Al Husseini 4, Jose G. Gomez-Arroyo 4, Norbert F. Voelkel 4, Herman J. Bogaard 5, New ...

Pulmonary arterial hypertension is a rare form of pulmonary hypertension that poses diagnostic challenges and often comes with a ... “but endothelial dysfunction induced by shear stress ...

What's new in the management of pulmonary hypertension among ... Cardiopulmonary bypass produces endothelial injury that includes ... With progressive RV dysfunction, pulmonary blood flow ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Conclusions: These results indicate that anti-VEGF drugs could cause endothelial dysfunction by decreasing L-Arginine bioavailability for NO synthesis and increasing sympathetic tone thereby resulting ...

Uncontrolled proliferation of endothelial cells in small pulmonary arteries is a key feature in the pathogenesis of pulmonary hypertension. Now it has been shown that small RNA fragments ...